Immucor Inc (BLUD) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3130 GATWAY NORCROSS, GA 30091 |
| State of Incorp. | GA |
| Fiscal Year End | May 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 2/28/2017 MRQ | 5/31/2016 | 5/31/2015 | 5/31/2014 | 5/31/2013 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 10,263 | 18,363 | 23,621 | 29,388 | |||
| Cash and cash equivalents | 10,263 | 18,363 | 23,621 | 29,388 | |||
| Receivables | 67,795 | 74,893 | 69,629 | 68,086 | |||
| Inventory, net of allowances, customer advances and progress billings | 46,894 | 41,847 | 49,151 | 45,941 | |||
| Inventory | 46,894 | 41,847 | 49,151 | 45,941 | |||
| Prepaid expense | 2,727 | 3,942 | 5,677 | 4,805 | |||
| Other current assets | 1,873 | ||||||
| Income taxes receivable | ✕ | ✕ | ✕ | 5,736 | 4,899 | ||
| Deferred tax assets | 5,931 | 8,251 | 5,290 | ||||
| Other undisclosed current assets | 1,169 | ||||||
| Total current assets: | 127,679 | 144,976 | 163,234 | 160,282 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 76,015 | 73,574 | 76,311 | 76,381 | |||
| Intangible assets, net (including goodwill) | 1,490,120 | 1,492,552 | 1,544,433 | 1,718,066 | |||
| Goodwill | 857,023 | 842,258 | 851,563 | 1,003,463 | |||
| Intangible assets, net (excluding goodwill) | 633,097 | 650,294 | 692,870 | 714,603 | |||
| Deferred costs | 26,399 | 33,116 | 39,449 | ||||
| Other noncurrent assets | 13,819 | 15,185 | 7,320 | 6,792 | |||
| Total noncurrent assets: | 1,579,954 | 1,607,710 | 1,661,180 | 1,840,688 | |||
| TOTAL ASSETS: | 1,707,633 | 1,752,686 | 1,824,414 | 2,000,970 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 65,692 | 80,183 | 49,188 | 69,329 | |||
| Interest and dividends payable | 18,869 | 19,288 | |||||
| Taxes payable | 2,585 | 6,840 | 9,807 | 8,953 | |||
| Employee-related liabilities | 13,981 | ||||||
| Accounts payable | 22,229 | 13,866 | 15,665 | 13,638 | |||
| Accrued liabilities | 22,009 | 26,208 | 23,716 | 46,738 | |||
| Debt | 4,469 | 4,591 | 6,712 | ||||
| Deferred revenue and credits | 2,864 | 2,703 | 2,813 | 2,252 | |||
| Other undisclosed current liabilities | 6,806 | (17,325) | 14,725 | (5,080) | |||
| Total current liabilities: | 75,362 | 70,030 | 71,317 | 73,213 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 1,007,948 | 1,033,276 | 1,037,183 | 1,039,278 | |||
| Long-term debt, excluding current maturities | 1,007,948 | 1,033,276 | 1,037,183 | 1,039,278 | |||
| Liabilities, other than long-term debt | 279,777 | 266,159 | 248,048 | 244,830 | |||
| Deferred revenue and credits | 208 | 210 | 161 | ||||
| Deferred tax liabilities, net | 222,357 | 236,487 | 223,379 | 231,040 | |||
| Other liabilities | 57,420 | 29,212 | 23,833 | 12,572 | |||
| Derivative instruments and hedges, liabilities | 252 | 626 | 1,057 | ||||
| Other undisclosed noncurrent liabilities | (460) | (750) | (1,057) | ||||
| Total noncurrent liabilities: | 1,287,725 | 1,298,975 | 1,284,481 | 1,283,051 | |||
| Total liabilities: | 1,363,087 | 1,369,005 | 1,355,798 | 1,356,264 | |||
| Equity | |||||||
| Equity, attributable to parent | 340,223 | 383,681 | 468,616 | 644,706 | |||
| Additional paid in capital | 753,709 | 755,234 | 753,147 | 751,635 | |||
| Accumulated other comprehensive loss | (39,407) | (39,564) | (13,267) | (17,922) | |||
| Accumulated deficit | (374,079) | (331,989) | (271,264) | (89,007) | |||
| Equity, attributable to noncontrolling interest | 4,323 | ||||||
| Total equity: | 344,546 | 383,681 | 468,616 | 644,706 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,707,633 | 1,752,686 | 1,824,414 | 2,000,970 | |||
Income Statement (P&L) ($ in thousands)
| 2/28/2017 TTM | 5/31/2016 | 5/31/2015 | 5/31/2014 | 5/31/2013 | ||
|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 379,972 | 389,300 | 388,056 | 347,788 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (17,462) | (20,022) | (20,165) | (18,718) | ||
| Other undisclosed gross profit | (126,507) | (123,637) | (119,469) | (101,309) | ||
| Gross profit: | 236,003 | 245,641 | 248,422 | 227,761 | ||
| Operating expenses | (207,089) | (202,368) | (358,372) | (191,017) | ||
| Operating income (loss): | 28,914 | 43,273 | (109,950) | 36,744 | ||
| Nonoperating expense | (90,644) | (88,398) | (88,223) | (100,452) | ||
| Interest and debt expense | (90,535) | (89,421) | (88,304) | (99,941) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 90,535 | 89,421 | 88,304 | 99,941 | ||
| Loss from continuing operations before income taxes: | (61,730) | (45,125) | (198,173) | (63,708) | ||
| Income tax expense (benefit) | 17,963 | (15,600) | 15,916 | 24,566 | ||
| Loss from continuing operations: | (43,767) | (60,725) | (182,257) | (39,142) | ||
| Loss before gain (loss) on sale of properties: | (43,767) | (60,725) | (182,257) | (39,142) | ||
| Net loss: | (43,767) | (60,725) | (182,257) | (39,142) | ||
| Net income attributable to noncontrolling interest | 1,677 | |||||
| Net loss available to common stockholders, diluted: | (42,090) | (60,725) | (182,257) | (39,142) | ||
Comprehensive Income ($ in thousands)
| 2/28/2017 TTM | 5/31/2016 | 5/31/2015 | 5/31/2014 | 5/31/2013 | ||
|---|---|---|---|---|---|---|
| Net loss: | (43,767) | (60,725) | (182,257) | (39,142) | ||
| Other comprehensive income (loss) | 157 | (26,297) | 4,655 | 1,821 | ||
| Comprehensive loss: | (43,610) | (87,022) | (177,602) | (37,321) | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 1,677 | |||||
| Comprehensive loss, net of tax, attributable to parent: | (41,933) | (87,022) | (177,602) | (37,321) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.